Back to state act
Description
On 16 March 2021, Novocol Pharmaceutical of Canada announced securing CAD 32.7 million (USD 26.2 million) from the government to expand its biomanufacturing facilities in Cambridge, Ontario. The contr...
Sign in to see full description
Intervention Details
Intervention Type
State loan
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
16 Mar 2021
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 32 products
Threads
See all
This intervention is not part of any Thread yet.